0000874716-23-000145.txt : 20231208
0000874716-23-000145.hdr.sgml : 20231208
20231208170021
ACCESSION NUMBER: 0000874716-23-000145
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231207
FILED AS OF DATE: 20231208
DATE AS OF CHANGE: 20231208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POLEWACZYK JAMES F
CENTRAL INDEX KEY: 0001389046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 231476203
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
wk-form4_1702072812.xml
FORM 4
X0508
4
2023-12-07
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001389046
POLEWACZYK JAMES F
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive Vice President
0
Common Stock
2023-12-07
4
M
0
4956
206.94
A
15005.9875
D
Common Stock
2023-12-07
4
M
0
6680
288.78
A
21685.9875
D
Common Stock
2023-12-07
4
S
0
3116
520.1922
D
18569.9875
D
Common Stock
2023-12-07
4
S
0
3378
521.0046
D
15191.9875
D
Common Stock
2023-12-07
4
S
0
1202
522.3094
D
13989.9875
D
Common Stock
2023-12-07
4
S
0
3940
523.5563
D
10049.9875
D
Non-Qualified Stock Option (right-to-buy)
206.94
2023-12-07
4
M
0
4956
0
D
2029-02-13
Common Stock
4956
755
D
Non-Qualified Stock Option (right-to-buy)
288.78
2023-12-07
4
M
0
6680
0
D
2030-02-13
Common Stock
6680
2226
D
Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on September 29, 2023.
Represents the weighted average price of the shares sold ranging from a low of $519.73 to a high of $520.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $520.74 to a high of $521.235 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $521.99 to a high of $522.935 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $523.05 to a high of $523.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
/s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
2023-12-08